ArticleDigestive diseases and sciences2026
Hypertriglyceridemia Screening in Acute Pancreatitis: Diagnostic Blind Spot in Clinical Routine.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertriglyceridemia (HTG) is the third most common cause of acute pancreatitis (AP) after gallstones and alcohol abuse. Early determination of the triglyceride (TG) level in patients with acute abdominal pain, particularly in cases of AP, is crucial, as an acute increase can be followed by a rapid decrease within 2 days. HTG as a cause of acute abdominal pain and AP is often overlooked in clinical practice. In addition, manifest HTG is often underdiagnosed and inadequately treated.
methodsWe investigated 1279 cases of acute abdominal pain, including 226 cases of AP, to assess the frequency and timing of TG level measurement. Additionally, we studied 237 patients with HTG levels above 500 mg/dL to determine the frequency of HTG-related symptoms and the rate of initiation of adequate therapy, considering the specialty in which the elevated TG levels were identified.
resultsTriglycerides were determined in 22% of patients with acute abdominal pain and 55% with AP; fewer than 15% of all patients received a determination at the first contact with the physician. TG levels were measured at a median of 24 h (1-54) in patients with acute abdominal pain and 48 h (24-95) in those with AP after admission. Less than half of patients with HTG received TG-lowering therapy. Only 5 of 226 cases with AP was identified as HTG-induced, while 13.5% of all cases with HTG above 500 mg/dL had a history of AP.
conclusionsOur findings support the assumption that HTG and its complications are often underestimated in clinical practice and require more attention. Furthermore, early initiation of appropriate therapy is crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.